‘Asthma Today’ Places New Research Patients’ Hands

September 1, 2015 at 12:04 am

Asthma Today e-bookletAsthma affects more than 26 million people in the U.S. and more than 300 million people worldwide. A new resource for asthma patients and their families has been released by the American Thoracic Society and is available as a free download. Asthma Today, an e-booklet supported by a generous donation from Teva Pharmaceuticals, reviews different types of asthma, diagnosis, classifications, triggers, treatments, and history, as well as the latest asthma research presented at the ATS 2015 International Conference. Also included are tips on creating an Asthma Action Plan.

“The importance of patients receiving the most up-to-date and accurate information about their conditions cannot be overstated,” says ATS Executive Director Stephen C. Crane, PhD, MPH. “With this new and valuable resource, those with asthma and their families will gain a better understanding not only of the condition but also an overview of new research that has the potential to change the way we think about treatment.”

Teva Pharmaceuticals SVP and General Manager Mark Salyer adds: “On behalf of TEVA Pharmaceuticals, it is our privilege to assist the ATS in their mission of ‘Helping the World Breathe’ by sponsoring Asthma Today. Like the ATS, Teva is committed to reducing the staggering levels of asthma in the U.S. and abroad.”

Download the e-booklet, and share it with your patients and colleagues today.

Asthma Today content was developed independently by the American Thoracic Society. Reviewers included Kevin Wilson, MD, chief of ATS Documents & Patient Education; Marianna Sockrider, MD, DrPH, the ATS associate medical editor for patient education; and Susan Tarlo, MD, asthma content expert.

DISCLAIMER: This e-booklet is intended for informational purposes only, with the understanding that no one should rely upon this information as the basis for medical decisions. Anyone requiring medical or other health care should consult a medical or health care professional. Any actions based on the information provided are entirely the responsibility of the user, and of any medical or other health care professionals who are involved in such actions. The American Thoracic Society (ATS), Teva Pharmaceuticals, and Ascend Integrated Media have used reasonable efforts to include timely and accurate information in this e-booklet. The ATS, Teva Pharmaceuticals, and Ascend Integrated Media make no representations or warranties, express or implied, regarding the accuracy or completeness of the information provided herein and specifically disclaim any liability, express or implied, in connection therewith. Photos in this booklet are used for illustrative purposes only. Any person depicted in the licensed material is a model, not an actual patient or health care professional.

Senior ATS staff met with Teva Pharmaceuticals leaders on Aug. 18 at their headquarters in Woodcliff Lake, New Jersey. From left: Chris Carney, Bonnie Ziegler, Tushar Shah, MD; Michelle Turenne, Mark Salyer, Tom Ferro, MD; Ron Wineinger, and Stephen Crane, PhD, MPH. Senior ATS staff met with Teva Pharmaceuticals leaders on Aug. 18 at their headquarters in Woodcliff Lake, New Jersey. From left: Chris Carney, Bonnie Ziegler, Tushar Shah, MD; Michelle Turenne, Mark Salyer, Tom Ferro, MD; Ron Wineinger, and Stephen Crane, PhD, MPH.

Advertisement

ATS 2016 Full Registration